113 related articles for article (PubMed ID: 23107473)
1. Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Pummer K; Zigeuner R
BJU Int; 2013 Apr; 111(4 Pt B):E191-5. PubMed ID: 23107473
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
[TBL] [Abstract][Full Text] [Related]
3. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
[TBL] [Abstract][Full Text] [Related]
4. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
[TBL] [Abstract][Full Text] [Related]
5. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
7. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?
Novara G; Ficarra V; Antonelli A; Artibani W; Bertini R; Carini M; Cosciani Cunico S; Imbimbo C; Longo N; Martignoni G; Martorana G; Minervini A; Mirone V; Montorsi F; Schiavina R; Simeone C; Serni S; Simonato A; Siracusano S; Volpe A; Carmignani G;
Eur Urol; 2010 Oct; 58(4):588-95. PubMed ID: 20674150
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
11. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
[TBL] [Abstract][Full Text] [Related]
12. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
13. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
15. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
[TBL] [Abstract][Full Text] [Related]
16. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Hirayama T; Okayasu I; Baba S
Urology; 2007 May; 69(5):839-42. PubMed ID: 17482918
[TBL] [Abstract][Full Text] [Related]
20. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
